Clinical trial

Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)

NCT00322543 · Conor Medsystems, Industry · Terminated

Key facts

NCT number NCT00322543
Title Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)
Official title Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID) A Multi-Center Study of the Pimecrolimus-Eluting Cobalt Chromium Coronary Stent System (Corio™) in Patients With De Novo Lesions of the Native Coronary Arteries
Lead sponsor Conor Medsystems, Industry
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Coronary Disease
Intervention type Device
Interventions Corio™ Pimecrolimus-eluting stent
Enrollment 3
Start date May 1, 2006
Primary completion Nov 1, 2006
Completion May 1, 2008
First posted May 8, 2006
Last update posted Oct 17, 2008
Countries Brazil

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies